483 3D Imaging Drug Design and Development Jan 2019

483 3D Imaging Drug Design and Development Jan 2019

Margaret Annes FDA$119.00 - Available Now

FDA investigators audited the 3D Imaging Drug Design and Development - Little Rock, AR, United States facility and issued inspectional observations (via FDA 483) on 18 Jan 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Jan 2019
  • Location: Little Rock, United States
  • FEI: 3009143510
Add To Cart